Market Overview

Global Occupational Medicines Market by Application and Industry - Forecast to 2025: A $5.79 Billion Opportunity -


The "Occupational
Medicines Market by Application, and Industry - Global Opportunity
Analysis and Industry Forecast, 2018-2025"
report has been
added to's offering.

The global occupational medicines market was valued at $3,753 million in
2017, and is estimated to reach at $5,794 million by 2025, registering a
CAGR of 5.5% from 2018 to 2025.

Rapid increase in the aging workforce and a favorable regulatory
environment toward occupational medicines supplement the growth of the
market. Furthermore, rise in awareness about occupational health is one
of the significant factors that drives the market growth.

However, surge in incorporation of automation and artificial
intelligence (AI) at the workplace, emergence of small businesses, and
change in industry structure are some of the factors that impede the
market growth.

Conversely, high potential of emerging economies and increase in demand
for occupational medicines are expected to provide new opportunities for
the market players during the forecast period.

Profiles for:

Key Players

  • Johnson & Johnson
  • Pfizer Inc.
  • Eli Lilly and Company
  • Galderma Laboratories L.P.
  • Novartis International AG
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Amgen Inc.
  • AstraZeneca
  • Sanofi SA

Other Players

  • Merck & Co. Inc.
  • AbbVie Inc.
  • GlaxoSmithKline PLC

Key Topics Covered

Chapter 1: Introduction

Chapter 2: Executive Summary

Chapter 3: Market Overview

Chapter 4: Occupational Medicines Market, by Application

Chapter 5: Occupational Medicines Market, by Industry

Chapter 6: Occupational Medicines Market, by Region

Chapter 7: Company Profiles

For more information about this report visit

View Comments and Join the Discussion!